Wendy Cruz, MD
Obstetrics & Gynecology · Anchorage, AKNPI 1003987595
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $705 of the $862 with a category attached, or 81.8%. It is spread thinly across 16 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $274, 4.6 times the $60 reported in 2019.
Across 35 payments — averaging $24.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$200
- Hologic Sales And Service, LLC$115
- AbbVie$78
- Sage Therapeutics, LLC$77
- Pfizer$71
- Intuitive Surgical$65
- plus $254 from 10 others
What the payments were for
- Food & beverage$70582%
- Education$15718%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $200 |
| Hologic Sales And Service, LLC | 4 | $115 |
| AbbVie | 5 | $78 |
| Sage Therapeutics, LLC | 3 | $77 |
| Pfizer | 4 | $71 |
| Intuitive Surgical | 1 | $65 |
| Myovant Sciences Inc. | 2 | $38 |
| Merck | 2 | $34 |
| Coopersurgical, Inc. | 2 | $30 |
| Bayer | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $19 |
| Coloplast | 1 | $19 |
| TMS Neurohealth Centers Inc. | 1 | $16 |
How this compares
$862 in reported general payments places this provider in the 65th percentile of 97 obstetrics & gynecology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $1,992 |
| Solifenacin Succinate | 11 | $262 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Anchorage
- Melissa TondreAnchorage$9K
- Patricia CapoAnchorage$9K
- Shiloh SmallAnchorage$9K
- Allison van HaastertAnchorage$6K
- Natalia SaprykinaAnchorage$6K
- Jessica GoldbergerAnchorage$6K
- Bradford FentonAnchorage$4K
- Julie CastleAnchorage$4K
- Tirza CannonAnchorage$3K
- Dana EspindolaAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.